Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45results about How to "Inhibit gastric acid secretion" patented technology

GLP-2 compounds, formulations, and uses thereof

InactiveUS7411039B2Reduces intestinal permeabilityInhibit gastric emptying and gastric acid secretionPeptide/protein ingredientsImmunoglobulinsPeptideChemistry
The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
Owner:NOVO NORDISK AS

Compositions and methods for inhibiting gastric acid secretion

The present invention is related to novel oral compositions comprising an irreversible gastric H+ / K+-ATPase proton pump inhibitor (PPI) as a gastric acid secretion inhibitor and one or more small carboxylic acid molecules as parietal cell activators in the gastric lumen. Unexpectedly, the compositions of the present invention are capable of enhancing the anti-acid activity of PPI in the stomach. The present invention further relates to a method of using such compositions to reduce gastric acid secretion in a mammal.
Owner:VECTA

Acid secretion inhibitor

ActiveUS20070060623A1Superior proton pump inhibitory effectInhibit gastric acid secretionAntibacterial agentsBiocideHalogenSecretion
The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity and the like. The present invention provides a compound represented by the formula (I) wherein R1 is a nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle, the nitrogen-containing monocyclic heterocyclic group optionally condensed with a benzene ring or a heterocycle optionally has substituent(s), R2 is an optionally substituted C6-14 aryl group, an optionally substituted thienyl group or an optionally substituted pyridyl group, R3 and R4 are each a hydrogen atom, or one of R3 and R4 is a hydrogen atom and the other is an optionally substituted lower alkyl group, an acyl group, a halogen atom, a cyano group or a nitro group, and R5 is an alkyl group or a salt thereof.
Owner:TAKEDA PHARMACEUTICALS CO LTD

Magnesium-S-omeprazole

The invention provides magnesium S-omeprazolato compounds according to formula (I): [Mg(solva)x(solvb)y][Mg(S-omeprazolato)3]2.(solvc)z  (I), pharmaceutical compositions and processes of making the same. In formula (I), solva, solvb, and solvc represent solvent molecules where x and y are independently selected from integers 0 to 6, the sum of which is 4 or 6, while z is a positive rational number from 0 to 6. The compounds are useful for the treatment of gastric acid related conditions and the inhibition of gastric acid secretion.
Owner:AAIPHARMA

Novel pyridine derivative

The invention belongs to the technical field of medicines and particularly relates to a novel pyridine derivative shown, stereoisomers of the pyridine derivative, pharmaceutically acceptable salts of the pyridine derivative, solvates of the pyridine derivate in the general formula (I) and intermediates shown in the general formulas (I') and (II), wherein R1, R2, R3, R4, R5 and n are as defined in a specification; the invention also relates to preparation methods for the compounds, a medicine combination containing the medicine compounds, and the application of the compounds in medicines for preventing and / or treating peptic ulcers, ulcer bleeding and diseases related to gastric acids.
Owner:SHANDONG XUANZHU PHARMA TECH CO LTD

Angelica keiskei tea and preparation method thereof

The invention discloses angelica keiskei tea which comprises 80-120 parts of angelica keiskei, 2-4 parts of fermented glutinous rice juice, 0.1-0.2 part of radix glycyrrhizae and an appropriate amount of saline water and brown sugar water, wherein the mass percent concentration of the saline water is 1.5-2.5%, and the mass percent concentration of the brown sugar water is 1.0-2.0%. The preparation method comprises a step (1) of picking fresh angelica keiskei leaves, cleaning and then draining the angelica keiskei leaves; a step (2) of soaking the angelica keiskei leaves in the saline water, fishing out the angelica keiskei leaves, and performing rinsing with clear water and draining; a step (3) of placing the angelica keiskei leaves in the brown sugar water to soak the angelica keiskei leaves, and then fishing out and draining the angelica keiskei leaves; a step (4) of preparing glycyrrhizae juice; a step (5) of taking and adding the fermented glutinous rice juice and the glycyrrhizae juice into the angelica keiskei leaves obtained in the step (3) to perform mixing, and then placing the angelica keiskei leaves in a tea manufacturing machine to perform preparation to obtain the angelica keiskei tea. The angelica keiskei tea is good in taste. The angelica keiskei tea has a certain health care effects of anticancer, antibiosis, anti-inflammation, pain relief, gastric acid secretion inhabitation, anti-ulcer, anti-thrombus, blood pressure reduction, blood sugar reduction, blood fat reduction and antianaphylaxis and the like.
Owner:贵州苗林王绿色生物科技有限公司

Sulfhydryl benzimidazole derivative containing dioxepane-pyridine

The invention belongs to the pharmaceutical technical field and specifically relates to hydrosulphonyl benzoglioxaline derivatives which are shown in general formula (I) and contain dioxo heptane pyridine, isomers and pharmaceutically acceptable salts thereof, wherein, R, R and R are defined as in the specification. The invention also relates to preparation methods of the compounds, drug compositions containing the compounds and the application of the compounds in preparing drugs for preventing and / or treating digestive ulcer.
Owner:SHANDONG XUANZHU PHARMA TECH CO LTD

Compound containing imidazopyridine

The invention belongs to the technical field of medicine, and in particular relates to compounds which are shown in a general formula (I) and contain imidazopyridine, pharmaceutically acceptable salts of the same and isomers of the same, wherein R, R, R, and X are defined in a specification. The invention also relates to a method for preparing the compounds, a pharmaceutical composition containing the compounds, and application of the compounds to preparation of medicines for preventing and / or treating peptic ulcer.
Owner:SHANDONG XUANZHU PHARMA TECH CO LTD

Imidazopyridine compound containing aminoxy substituted pyridine

The invention belongs to the technical field of medicine, and in particular relates to compounds of imidazopyridine which are shown in a general formula (I) and contain aminooxy substituted pyridine, pharmaceutically acceptable salts of the same and isomers of the same, wherein R, R, R and R are defined in a specification. The invention also relates to a method for preparing the compounds, a pharmaceutical composition containing the compounds, and application of the compounds to preparation of medicines for preventing and / or treating peptic ulcer.
Owner:SHANDONG XUANZHU PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products